{"id":1016356,"date":"2026-11-02T16:08:34","date_gmt":"2026-11-02T21:08:34","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\/"},"modified":"2026-11-02T16:08:34","modified_gmt":"2026-11-02T21:08:34","slug":"dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\/","title":{"rendered":"Dianthus Therapeutics to Participate in Five Investor Conferences During November"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK and WALTHAM, Mass., Nov.  02, 2026  (GLOBE NEWSWIRE) &#8212; Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced the Company\u2019s participation in five investor conferences.<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>Guggenheim 3rd Annual Healthcare Innovation Conference: <\/strong>Marino Garcia, CEO, will participate in a fireside chat on Monday, November 9, 2026, at 11:00 a.m. ET. Marino Garcia and Ryan Savitz, EVP, CFO &amp; CBO, will also host one-on-one investor meetings.<\/p>\n<\/li>\n<li>\n          <strong>Stifel 2026 Healthcare Conference: <\/strong>Marino Garcia will participate in a fireside chat on Wednesday, November 11, 2026, at 9:20 a.m. ET. Marino Garcia and Ryan Savitz will also host one-on-one investor meetings.<\/p>\n<\/li>\n<li>\n          <strong>2026 Truist Securities BioPharma Symposium: <\/strong>Ryan Savitz will host one-on-one investor meetings on Thursday, November 12, 2026.<\/p>\n<\/li>\n<li>\n          <strong>UBS Global Biopharma Conference: <\/strong>Marino Garcia will participate in a fireside chat on Monday, November 16, 2026, at 9:20 a.m. GMT. Marino Garcia and Ryan Savitz will also host one-on-one investor meetings.<\/p>\n<\/li>\n<li>\n          <strong>Jefferies Global Healthcare Conference: <\/strong>Marino Garcia will participate in a fireside chat on Wednesday, November 18, 2026, at 2:30 p.m. GMT. Marino Garcia and Ryan Savitz will also host one-on-one investor meetings.<\/li>\n<\/ul>\n<p>Webcasts of the fireside chats may be accessed under \u201cNews and Events\u201d in the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=233dofip4XeJ42hNodP0txeHvwYuwfZ4AJvp4n_457v2ANSo71Veohfhi0MtExJ5kn16Gl9eZ-SfD-aHkTBiO5Pwvuvd5ozKtFSrdvFKT3s=\" rel=\"nofollow\" target=\"_blank\">Investors<\/a> section of the Dianthus Therapeutics <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ItIqbwtuZ2YrWyYD3XgkULqihHNuRx-nVrV_HHZ34_w6F04VMsCVgPUViFaN14Q1ZmeqonTuHhc-cgsalt_i6g==\" rel=\"nofollow\" target=\"_blank\">website<\/a>.<\/p>\n<p>\n        <strong>About Dianthus Therapeutics<\/strong><br \/>\n        <br \/>Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases. Based in New York City and Waltham, Mass., Dianthus is comprised of an experienced team of biotech and pharma executives who aim to deliver transformative medicines for people living with severe autoimmune and inflammatory diseases.<\/p>\n<p>To learn more, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_YfZMHhbrD76O227APDUjgacpCohIIle0Q1q38_uK4VGFjmybGdEL-z2cRgnruWz0XwtwOqk0rEXmh2VpcPzdcOjJV4wg6y9W3rzk4D_3_M=\" rel=\"nofollow\" target=\"_blank\"><u>www.dianthustx.com<\/u><\/a> and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-4Y0GCLxrFo2FAm4AnjTvGYGp9K-aE2r6EK3_-l4E9pYirHym6BHaQpWqz5yqVHqCedNlcw_pqchYtzNHJsNV03zwimYWXb5aKu-nyIKrfwp-TRo9azpHo8reztySNLSNTVwNGOTAuWBnngc6z8CtQ==\" rel=\"nofollow\" target=\"_blank\"><u>LinkedIn<\/u><\/a>.\u00a0<\/p>\n<p>\n        <strong>Contact <\/strong><br \/>\n        <br \/>Jennifer Davis Ruff<br \/>Dianthus Therapeutics<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=f2AycOlzfFiCpkDCUN5_TD1mTX4yR4A-6C5pMTXVk76N1zGupExw_ZlbUz1dxMRGYv8mSKCL5ml9vWNx2gHvZ5L0J7KqziwZGVcYyzx5nBMzk4TAih_YNjG4PmUJ5aD0\" rel=\"nofollow\" target=\"_blank\">jdavisruff@dianthustx.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NzM3OSM3OTI3MTY3IzIyNjAzODk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MjQ0YjNiMjUtNWIxYS00ZWU2LWIzZTEtYWFjYWMyMTBkYTJkLTEyNzE5MzktMjAyNi0xMS0wMi1lbg==\/tiny\/Dianthus-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK and WALTHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) &#8212; Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced the Company\u2019s participation in five investor conferences. Guggenheim 3rd Annual Healthcare Innovation Conference: Marino Garcia, CEO, will participate in a fireside chat on Monday, November 9, 2026, at 11:00 a.m. ET. Marino Garcia and Ryan Savitz, EVP, CFO &amp; CBO, will also host one-on-one investor meetings. Stifel 2026 Healthcare Conference: Marino Garcia will participate in a fireside chat on Wednesday, November 11, 2026, at 9:20 a.m. ET. Marino Garcia and Ryan Savitz will also host one-on-one investor meetings. 2026 Truist Securities BioPharma Symposium: Ryan Savitz &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Dianthus Therapeutics to Participate in Five Investor Conferences During November&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1016356","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Dianthus Therapeutics to Participate in Five Investor Conferences During November - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dianthus Therapeutics to Participate in Five Investor Conferences During November - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK and WALTHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) &#8212; Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced the Company\u2019s participation in five investor conferences. Guggenheim 3rd Annual Healthcare Innovation Conference: Marino Garcia, CEO, will participate in a fireside chat on Monday, November 9, 2026, at 11:00 a.m. ET. Marino Garcia and Ryan Savitz, EVP, CFO &amp; CBO, will also host one-on-one investor meetings. Stifel 2026 Healthcare Conference: Marino Garcia will participate in a fireside chat on Wednesday, November 11, 2026, at 9:20 a.m. ET. Marino Garcia and Ryan Savitz will also host one-on-one investor meetings. 2026 Truist Securities BioPharma Symposium: Ryan Savitz &hellip; Continue reading &quot;Dianthus Therapeutics to Participate in Five Investor Conferences During November&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-02T21:08:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NzM3OSM3OTI3MTY3IzIyNjAzODk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Dianthus Therapeutics to Participate in Five Investor Conferences During November\",\"datePublished\":\"2026-11-02T21:08:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\\\/\"},\"wordCount\":292,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NzM3OSM3OTI3MTY3IzIyNjAzODk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\\\/\",\"name\":\"Dianthus Therapeutics to Participate in Five Investor Conferences During November - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NzM3OSM3OTI3MTY3IzIyNjAzODk=\",\"datePublished\":\"2026-11-02T21:08:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NzM3OSM3OTI3MTY3IzIyNjAzODk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NzM3OSM3OTI3MTY3IzIyNjAzODk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dianthus Therapeutics to Participate in Five Investor Conferences During November\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dianthus Therapeutics to Participate in Five Investor Conferences During November - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\/","og_locale":"en_US","og_type":"article","og_title":"Dianthus Therapeutics to Participate in Five Investor Conferences During November - Market Newsdesk","og_description":"NEW YORK and WALTHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) &#8212; Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced the Company\u2019s participation in five investor conferences. Guggenheim 3rd Annual Healthcare Innovation Conference: Marino Garcia, CEO, will participate in a fireside chat on Monday, November 9, 2026, at 11:00 a.m. ET. Marino Garcia and Ryan Savitz, EVP, CFO &amp; CBO, will also host one-on-one investor meetings. Stifel 2026 Healthcare Conference: Marino Garcia will participate in a fireside chat on Wednesday, November 11, 2026, at 9:20 a.m. ET. Marino Garcia and Ryan Savitz will also host one-on-one investor meetings. 2026 Truist Securities BioPharma Symposium: Ryan Savitz &hellip; Continue reading \"Dianthus Therapeutics to Participate in Five Investor Conferences During November\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-02T21:08:34+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NzM3OSM3OTI3MTY3IzIyNjAzODk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Dianthus Therapeutics to Participate in Five Investor Conferences During November","datePublished":"2026-11-02T21:08:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\/"},"wordCount":292,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NzM3OSM3OTI3MTY3IzIyNjAzODk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\/","name":"Dianthus Therapeutics to Participate in Five Investor Conferences During November - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NzM3OSM3OTI3MTY3IzIyNjAzODk=","datePublished":"2026-11-02T21:08:34+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NzM3OSM3OTI3MTY3IzIyNjAzODk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NzM3OSM3OTI3MTY3IzIyNjAzODk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dianthus-therapeutics-to-participate-in-five-investor-conferences-during-november\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Dianthus Therapeutics to Participate in Five Investor Conferences During November"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1016356","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1016356"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1016356\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1016356"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1016356"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1016356"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}